Chemokine expression in renal ischemia/reperfusion injury is most profound during the reparative phase.
Chemokines are important players in the migration of leukocytes to sites of injury and are also involved in angiogenesis, development and wound healing. In this study, we performed microarray analyses to identify chemokines that play a role during the inflammatory and repair phase after renal ischemia/reperfusion (I/R) injury and investigated the temporal relationship between chemokine expression, leukocyte accumulation and renal damage/repair. C57Bl/6 mice were subjected to unilateral ischemia for 45 min and sacrificed 3 h, 1 day and 7 days after reperfusion. From ischemic and contralateral kidney, RNA was isolated and hybridized to a microarray. Microarray results were validated with quantitative real-time reverse transcription-PCR (QRT-PCR) on RNA from an independent experiment. (Immuno)histochemical analyses were performed to determine renal damage/repair and influx of leukocytes. Twenty out of 114 genes were up-regulated at one or more reperfusion periods. All these genes were up-regulated 7 days after I/R. Up-regulated genes included CC chemokines MCP-1 and TARC, CXC chemokines KC and MIP-2alpha, chemokine receptors Ccr1 and Cx3cr1 and related genes like matrix metalloproteinases. Microarray data of 1 and 7 days were confirmed for 17 up-regulated genes by QRT-PCR. (Immuno)histochemical analysis showed that the inflammatory and repair phase after renal I/R injury take place after, respectively, 1 and 7 days. Interestingly, chemokine expression was highest during the repair phase. In addition, expression profiles showed a biphasic expression of all up-regulated CXC chemokines coinciding with the early inflammatory and late repair phase. In conclusion, we propose that temporal expression of chemokines is a crucial factor in the regulation of renal I/R injury and repair.
Stroo
Ingrid
I
Department of Pathology, Academic Medical Center, University of Amsterdam, The Netherlands. i.stroo@amc.uva.nl <i.stroo@amc.uva.nl>
Stokman
Geurt
G
Teske
Gwen J D
GJ
Raven
Anje
A
Butter
Loes M
LM
Florquin
Sandrine
S
Leemans
Jaklien C
JC
D000818:Animals; D002452:Cell Count; D018925:Chemokines / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D020869:Gene Expression Profiling; D006801:Humans; D007120:Immunochemistry; D007249:Inflammation; D007668:Kidney / Q000276:immunology* / Q000378:metabolism / Q000473:pathology / Q000601:surgery; D008264:Macrophages / Q000473:pathology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D046228:Microarray Analysis; D009504:Neutrophils / Q000473:pathology; D019707:Receptors, Chemokine / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D015427:Reperfusion Injury / Q000276:immunology* / Q000473:pathology / Q000503:physiopathology; D013601:T-Lymphocytes / Q000473:pathology
D018925:Chemokines; D019707:Receptors, Chemokine
J Am Soc Nephrol. 2003 Apr;14(4):1066-71
12660342
Pharmacol Ther. 2006 Oct;112(1):139-49
16720046
Am Fam Physician. 2000 Apr 1;61(7):2077-88
10779250
Nephron Exp Nephrol. 2008;109(1):c29-38
18520167
Am J Physiol. 1989 May;256(5 Pt 2):F794-802
2541628
J Am Soc Nephrol. 2003 Oct;14(10):2503-15
14514728
Kidney Int. 1998 Mar;53(3):726-34
9507220
Am J Physiol. 1991 Dec;261(6 Pt 2):F1095-101
1750520
Arthritis Rheum. 2003 Sep;48(9):2555-66
13130475
J Am Soc Nephrol. 2000 Jan;11(1):152-176
10616852
J Am Soc Nephrol. 2006 Mar;17(3):716-23
16481416
Am J Physiol Renal Physiol. 2004 Mar;286(3):F581-9
14600031
Methods Mol Biol. 2000;132:365-86
10547847
J Clin Invest. 2005 Oct;115(10):2894-903
16167081
J Am Soc Nephrol. 2006 Feb;17(2):454-64
16382019
Kidney Int. 2003 Feb;63(2):401-15
12631106
Arthritis Rheum. 2005 May;52(5):1522-33
15880599
Kidney Int. 2009 Mar;75(5):526-35
19092796
Am J Physiol Renal Physiol. 2008 Jan;294(1):F264-71
18003857
J Leukoc Biol. 2006 Jan;79(1):114-22
16275892
Cell Immunol. 2007 Jul;248(1):4-11
17942086
J Am Soc Nephrol. 2005 Jun;16(6):1684-92
15829714
J Immunol. 1995 Jun 1;154(11):6048-57
7751647
Am J Pathol. 2006 Aug;169(2):372-87
16877340
Eur J Immunol. 2004 Jun;34(6):1617-26
15162431
Diabetologia. 2007 Feb;50(2):471-80
17160673
J Hypertens. 1997 Dec;15(12 Pt 1):1365-77
9431840
Eur J Immunol. 2002 Jul;32(7):2037-45
12115625
Leukemia. 2008 Mar;22(3):466-73
17972941
Am J Pathol. 2001 Dec;159(6):2137-45
11733364
J Pathol. 2008 Jan;214(1):104-13
17973244
Cell Mol Immunol. 2004 Apr;1(2):95-104
16212895
J Am Soc Nephrol. 2005 Jul;16(7):2034-43
15901765
PLoS One. 2008;3(10):e3596
18974879
Kidney Int. 2006 Jan;69(1):73-80
16374426
Eur J Immunol. 2002 Nov;32(11):3197-205
12555665
Immunol Rev. 2000 Oct;177:195-203
11138776
J Clin Invest. 2008 Nov;118(11):3522-30
18982158
N Engl J Med. 2006 Feb 9;354(6):610-21
16467548
J Exp Med. 1998 Feb 16;187(4):601-8
9463410
Annu Rev Immunol. 2000;18:217-42
10837058
Rheumatology (Oxford). 2004 Sep;43(9):1121-8
15213333
FASEB J. 1999 Sep;13(12):1565-74
10463948
J Am Soc Nephrol. 2006 Jan;17(1):131-40
16291841
J Leukoc Biol. 1995 Sep;58(3):359-64
7665992
Curr Pharm Des. 2006;12(23):2923-34
16918422
Neurosci Lett. 2003 Mar 13;339(1):62-6
12618301
Aliment Pharmacol Ther. 2000 Apr;14 Suppl 1:94-100
10807410